Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEGVISOMANT Cause Product preparation issue? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product preparation issue have been filed in association with PEGVISOMANT (SOMAVERT). This represents 0.4% of all adverse event reports for PEGVISOMANT.

11
Reports of Product preparation issue with PEGVISOMANT
0.4%
of all PEGVISOMANT reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product preparation issue From PEGVISOMANT?

Of the 11 reports, 1 (9.1%) required hospitalization.

Is Product preparation issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEGVISOMANT. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does PEGVISOMANT Cause?

Off label use (460) Drug ineffective (328) Insulin-like growth factor increased (320) Product dose omission issue (255) Headache (244) Fatigue (224) Arthralgia (184) Death (162) Injection site pain (161) Product use issue (158)

What Other Drugs Cause Product preparation issue?

ONABOTULINUMTOXINA (677) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (252) HUMAN C1-ESTERASE INHIBITOR (238) SOMATROPIN (200) INCOBOTULINUMTOXINA (174) STIRIPENTOL (129) TESAMORELIN (119) ABATACEPT (115) INFLIXIMAB (101) ABOBOTULINUMTOXINA (91)

Which PEGVISOMANT Alternatives Have Lower Product preparation issue Risk?

PEGVISOMANT vs PEGZEREPOETIN ALFA PEGVISOMANT vs PEMBROLIZUMAB PEGVISOMANT vs PEMETREXED PEGVISOMANT vs PEMIGATINIB PEGVISOMANT vs PENICILLAMINE

Related Pages

PEGVISOMANT Full Profile All Product preparation issue Reports All Drugs Causing Product preparation issue PEGVISOMANT Demographics